TrialThe oncologist2019

Phase II Study of Bendamustine and Ofatumumab in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy.

Ian W Flinn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.